[Stent thrombosis in patients with myocardial infarction].
The problem of stent thrombosis in patients with myocardial infarction is reviewed with consideration of possible mechanisms and causes of in-stent thrombus formation during first 30 days after the procedure. Roles of the patient factor, factor of the stented vessel, stent in self, stent deployment technique, and management after stenting are discussed.
Rogan
S V
SV
Arablinskiĭ
A V
AV
Solov'ev
O P
OP
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000379:methods; D001241:Aspirin / Q000627:therapeutic use; D017023:Coronary Angiography; D003328:Coronary Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000517:prevention & control; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000187:drug effects; D012307:Risk Factors; D015607:Stents / Q000009:adverse effects* / Q000592:standards; D013988:Ticlopidine / Q000627:therapeutic use; D013997:Time Factors; D018084:Ultrasonography, Interventional
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D013988:Ticlopidine; D001241:Aspirin